首頁 > 市場調查報告書 > 醫療設備

透析設備

市場調查報告書

商品編碼

1746487

日本血液成分分析市場報告（血漿、血小板、白血球、淋巴球、紅血球）、產品、技術、流程、應用、最終使用者及地區（2025-2033）

Japan Apheresis Market Report by Component (Plasma, Platelets, Leukocytes, Lymphocytes, RBC's ), Product, Technology, Procedure, Application, End User, and Region 2025-2033

出版日期: 2025年06月02日 | 出版商:

IMARC | 英文 120 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年，日本血液分離市場規模達1.426億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到2.529億美元，2025-2033年期間的複合年成長率（CAGR）為6.08%。癌症、自體免疫疾病和血液相關疾病等慢性疾病發生率的上升，血液分離設備的快速技術進步，醫護人員和患者對血液分離程序益處的認知不斷提高，以及醫療基礎設施的大量投資，都是推動市場發展的一些因素。

血液分離術是一種具有治療用途的醫療程序，涉及從捐贈者或患者體內分離和提取特定血液成分。該過程使用一種稱為血液分離機的精密機器，可以選擇性地提取和保留血液成分，例如血漿、血小板、紅血球或白血球。根據目標血液成分，分離過程透過離心或過濾實現。血液分離術的主要治療應用之一是治療各種疾病，包括自體免疫疾病、血液疾病和神經系統疾病。例如，對於多發性硬化症或重症肌無力等自體免疫疾病，血液分離術可以去除患者血液中的有害抗體，從而減輕疾病的影響。同樣，對於白血病等血液疾病，血液分離術有助於收集用於治療或移植的特定血液成分。此外，它在捐血過程中也發揮著至關重要的作用，可以收集各種醫療所需的特定成分，並將剩餘成分送回捐贈者體內。這種定向血液成分採集提高了捐血效率，確保了醫療干預所需的穩定且多樣化的血液製品供應。不斷發展的血液分離技術持續推動治療和捐贈相關醫療實踐的進步，為臨床醫生提供了一種強大的工具，可以選擇性地管理血液成分，從而造福於面臨各種健康挑戰的患者。

日本血液分離市場趨勢：

日本市場主要受治療應用範圍不斷擴大的驅動。同時，血液分離機技術的快速進步也顯著促進了市場成長。設備設計、自動化程度和血液成分分離精度的不斷創新，提高了血液分離程序的效率和安全性，使其更容易獲得，也更受醫療服務提供者的青睞。這些技術進步也縮短了手術時間，提高了患者的舒適度，進一步推動了血液分離技術在臨床環境中的應用。此外，慢性疾病和自體免疫疾病的盛行率不斷上升，也刺激了對血液分離程序的需求。癌症、自體免疫疾病和血液疾病等疾病通常需要有針對性地提取或採集特定的血液成分，以控制症狀或輔助治療。血液分離是一種至關重要的治療干預措施，它能夠選擇性地提取與疾病相關的成分，有助於疾病管理並改善患者的預後。隨著慢性疾病負擔的持續增加，對血液分離程序作為一種治療選擇的需求預計將成長。此外，血液分離技術的廣泛治療應用也拓展了其市場潛力。除了傳統用途外，血液分離術在神經內科、腎臟科、血液科以及其他醫學專科領域也得到了廣泛的應用。這種多樣化的應用使血液分離術成為各種醫療保健場景中用途廣泛且極具價值的工具，並推動了其市場的持續成長。此外，醫療保健專業人員對血液分離術在治療各種疾病方面的益處的認知不斷提高，也進一步推動了其應用。

日本血液分離市場細分：

組件洞察：

血漿（血漿置換）
血小板（血小板單採）
白血球（白血球分離術或白血球去除術）
淋巴球（淋巴球分離術或淋巴球分離術）
紅血球（紅血球分離術）

產品洞察：

裝置
耗材和試劑
軟體

技術洞察：

離心
膜分離
選擇性吸附

程式見解：

捐贈者/自動血液分離術
治療性血液分離術

應用程式洞察：

腎臟疾病
血液系統疾病
神經系統疾病
自體免疫疾病
其他

最終用戶洞察：

血液中心
醫院
其他

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀錶板和公司評估象限等競爭分析。此外，報告還提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本血液分離市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本血液分離市場有何影響？
日本血液成分分析市場以成分分類是怎樣的？
日本血液成分分析市場依產品分類是怎樣的？
日本血液成分分析市場依技術分類是怎樣的？
日本血液成分分析市場依程序的分類是怎樣的？
日本血液成分分析市場依應用如何分類？
根據最終用戶，日本血液成分分析市場的分佈是如何的？
日本血液分離市場的價值鏈分為哪些階段？
日本血液分離術的主要促進因素和挑戰是什麼？
日本血液分離市場的結構是怎麼樣的？主要參與者是誰？
日本血液淨化市場的競爭程度如何？

本報告回答的關鍵問題：

日本血液分離市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本血液分離市場有何影響？
日本血液成分分析市場以成分分類是怎樣的？
日本血液成分分析市場依產品分類是怎樣的？
日本血液成分分析市場依技術分類是怎樣的？
日本血液成分分析市場依程序的分類是怎樣的？
日本血液成分分析市場依應用如何分類？
根據最終用戶，日本血液成分分析市場的分佈是怎樣的？
日本血液分離市場的價值鏈分為哪些階段？
日本血液分離術的主要促進因素和挑戰是什麼？
日本血液分離市場的結構是怎麼樣的？主要參與者是誰？
日本血液淨化市場的競爭程度如何？

Japan apheresis market size reached USD 142.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 252.9 Million by 2033, exhibiting a growth rate (CAGR) of 6.08% during 2025-2033. The increasing incidence of chronic diseases such as cancer, autoimmune disorders, and blood-related conditions, the rapid technological advancements in apheresis equipment, the rising awareness among healthcare professionals and patients about the benefits of apheresis procedures, and the heavy investments in healthcare infrastructure are some of the factors propelling the market.

Apheresis, a medical procedure with therapeutic applications, involves the separation and removal of specific blood components from a donor or patient. The process utilizes a sophisticated machine known as an apheresis machine, which allows for the selective extraction and retention of blood components, such as plasma, platelets, red blood cells, or white blood cells. This separation is achieved through centrifugation or filtration, depending on the targeted blood component. One of the primary therapeutic applications of it is in the treatment of various medical conditions, including autoimmune disorders, hematologic diseases, and neurological disorders. For example, in autoimmune diseases like multiple sclerosis or myasthenia gravis, apheresis can remove harmful antibodies from the patient's blood, mitigating the impact of the disease. Similarly, in hematologic disorders like leukemia, apheresis aids in collecting specific blood components for therapeutic use or transplantation. Additionally, it plays a crucial role in blood donation processes, allowing for the collection of specific components needed for various medical treatments while returning the remaining components to the donor. This targeted blood component collection enhances the efficiency of blood donation practices, ensuring a steady and diverse supply of blood products for medical interventions. The evolving field of apheresis continues to contribute to advancements in therapeutic and donation-related medical practices, providing clinicians with a powerful tool to selectively manage blood components to benefit patients facing a spectrum of health challenges.

Japan Apheresis Market Trends:

The market in Japan is majorly driven by the expanding scope of therapeutic applications. In line with this, the rapid advancements in apheresis machine technologies contribute significantly to market growth. Continuous innovations in device design, automation, and precision in blood component separation enhance the efficiency and safety of apheresis procedures, making them more accessible and attractive to healthcare providers. These technological enhancements also lead to reduced procedure times and improved patient comfort, further driving the adoption of apheresis in clinical settings. Furthermore, the rising prevalence of chronic and autoimmune diseases fuels the demand for apheresis procedures. Conditions such as cancer, autoimmune disorders, and hematologic diseases often require targeted removal or collection of specific blood components to manage symptoms or facilitate treatments. Apheresis serves as a crucial therapeutic intervention by allowing the selective extraction of disease-related components, contributing to disease management and improving patient outcomes. As the burden of chronic diseases continues to increase, the demand for apheresis procedures as a therapeutic option is expected to grow. Besides, the widespread therapeutic applications for apheresis broaden its market potential. Beyond traditional uses, apheresis is finding applications in neurology, nephrology, and hematology, among other medical specialties. This diversification of applications positions apheresis as a versatile and valuable tool in various healthcare scenarios, contributing to its sustained market growth. Additionally, the growing awareness among healthcare professionals about the benefits of apheresis in managing a wide range of medical conditions further propels its adoption.

Japan Apheresis Market Segmentation:

Component Insights:

Plasma (Plasmapheresis)
Platelets (Plateletpheresis)
Leukocytes (Leukapheresis or Leukopheresis)
Lymphocytes (Lymphopheresis or Lymphapheresis)
RBC's (Erythropheresis)

Product Insights:

Devices
Disposables and Reagents
Software

Technology Insights:

Centrifugation
Membrane Separation
Selective Adsorption

Procedure Insights:

Donor/Automated Apheresis
Therapeutic Apheresis

Application Insights:

Renal Disorders
Hematological Disorders
Neurological Disorders
Autoimmune Disorders
Others

End User Insights:

Blood Centers
Hospitals
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan apheresis market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan apheresis market?
What is the breakup of the Japan apheresis market on the basis of component?
What is the breakup of the Japan apheresis market on the basis of product?
What is the breakup of the Japan apheresis market on the basis of technology?
What is the breakup of the Japan apheresis market on the basis of procedure?
What is the breakup of the Japan apheresis market on the basis of application?
What is the breakup of the Japan apheresis market on the basis of end user?
What are the various stages in the value chain of the Japan apheresis market?
What are the key driving factors and challenges in the Japan apheresis?
What is the structure of the Japan apheresis market and who are the key players?
What is the degree of competition in the Japan apheresis market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Apheresis Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Apheresis Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Apheresis Market - Breakup by Component

6.1 Plasma (Plasmapheresis)
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Platelets (Plateletpheresis)
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Leukocytes (Leukapheresis or Leukopheresis)
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
6.4 Lymphocytes (Lymphopheresis or Lymphapheresis)
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
6.5 RBC's (Erythropheresis)
- 6.5.1 Overview
- 6.5.2 Historical and Current Market Trends (2019-2024)
- 6.5.3 Market Forecast (2025-2033)

7 Japan Apheresis Market - Breakup by Product

7.1 Devices
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Disposables and Reagents
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Software
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)

8 Japan Apheresis Market - Breakup by Technology

8.1 Centrifugation
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Membrane Separation
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Selective Adsorption
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)

9 Japan Apheresis Market - Breakup by Procedure

9.1 Donor/Automated Apheresis
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Therapeutic Apheresis
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)

10 Japan Apheresis Market - Breakup by Application

10.1 Renal Disorders
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2019-2024)
- 10.1.3 Market Forecast (2025-2033)
10.2 Hematological Disorders
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2019-2024)
- 10.2.3 Market Forecast (2025-2033)
10.3 Neurological Disorders
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2019-2024)
- 10.3.3 Market Forecast (2025-2033)
10.4 Autoimmune Disorders
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2019-2024)
- 10.4.3 Market Forecast (2025-2033)
10.5 Others
- 10.5.1 Historical and Current Market Trends (2019-2024)
- 10.5.2 Market Forecast (2025-2033)

11 Japan Apheresis Market - Breakup by End User

11.1 Blood Centers
- 11.1.1 Overview
- 11.1.2 Historical and Current Market Trends (2019-2024)
- 11.1.3 Market Forecast (2025-2033)
11.2 Hospitals
- 11.2.1 Overview
- 11.2.2 Historical and Current Market Trends (2019-2024)
- 11.2.3 Market Forecast (2025-2033)
11.3 Others
- 11.3.1 Historical and Current Market Trends (2019-2024)
- 11.3.2 Market Forecast (2025-2033)

12 Japan Apheresis Market - Competitive Landscape

12.1 Overview
12.2 Market Structure
12.3 Market Player Positioning
12.4 Top Winning Strategies
12.5 Competitive Dashboard
12.6 Company Evaluation Quadrant

13 Profiles of Key Players

13.1 Company A
- 13.1.1 Business Overview
- 13.1.2 Product Portfolio
- 13.1.3 Business Strategies
- 13.1.4 SWOT Analysis
- 13.1.5 Major News and Events
13.2 Company B
- 13.2.1 Business Overview
- 13.2.2 Product Portfolio
- 13.2.3 Business Strategies
- 13.2.4 SWOT Analysis
- 13.2.5 Major News and Events
13.3 Company C
- 13.3.1 Business Overview
- 13.3.2 Product Portfolio
- 13.3.3 Business Strategies
- 13.3.4 SWOT Analysis
- 13.3.5 Major News and Events
13.4 Company D
- 13.4.1 Business Overview
- 13.4.2 Product Portfolio
- 13.4.3 Business Strategies
- 13.4.4 SWOT Analysis
- 13.4.5 Major News and Events
13.5 Company E
- 13.5.1 Business Overview
- 13.5.2 Product Portfolio
- 13.5.3 Business Strategies
- 13.5.4 SWOT Analysis
- 13.5.5 Major News and Events

14 Japan Apheresis Market - Industry Analysis

14.1 Drivers, Restraints, and Opportunities
- 14.1.1 Overview
- 14.1.2 Drivers
- 14.1.3 Restraints
- 14.1.4 Opportunities
14.2 Porters Five Forces Analysis
- 14.2.1 Overview
- 14.2.2 Bargaining Power of Buyers
- 14.2.3 Bargaining Power of Suppliers
- 14.2.4 Degree of Competition
- 14.2.5 Threat of New Entrants
- 14.2.6 Threat of Substitutes
14.3 Value Chain Analysis